Brief: Nyxoah: Full-Body 1.5T And 3T MRI Compatibility For Genio System
Jan 26 (Reuters) - Nyxoah SA NYXH.BR :
* NYXOAH ANNOUNCES FULL-BODY 1.5T AND 3T MRI COMPATIBILITY
FOR THE
GENIO SYSTEM TO TREAT OBSTRUCTIVE SLEEP APNEA (OSA)
* RECEIVED CE MARK MAGNETIC RESONANCE IMAGING (MRI)
CONDITIONAL
LABELING FOR CURRENT GENIO NEUROSTIMULATION-BASED OSA THERAPY
Source text for Eikon: ID:nGNE9kjWgF
Further company coverage: NYXH.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nyxoah SA
See all newsBelgium's Nyxoah Q3 revenue rises on US commercialization
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer